|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Accounts receivable | ||||||||||
| Short-term investments | ||||||||||
| Restricted cash | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right of use asset, net | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and Stockholders' Equity | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Operating lease liability | ||||||||||
| Total current liabilities | ||||||||||
| Operating lease liability, net of current portion | ||||||||||
| Total liabilities | ||||||||||
| Stockholders' equity | ||||||||||
| Undesignated preferred stock, $0.001 par value; 10,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively; zero shares issued and outstanding at September 30, 2026 and December 31, 2025 | ||||||||||
| Common stock, $0.001 par value; 500,000,000 shares authorized at September 30, 2026 and December 31, 2025; 48,088,413 shares and 47,772,567 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...